Cargando…
Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors
Chimeric antigen receptor (CAR) T cells demonstrate remarkable success in treating hematological malignancies, but their effectiveness in non-hematopoietic cancers remains limited. This study proposes enhancing CAR T cell function and localization in solid tumors by modifying the epigenome governing...
Autores principales: | Jung, In-Young, Noguera-Ortega, Estela, Bartoszek, Robert, Collins, Sierra M., Williams, Erik, Davis, Megan, Jadlowsky, Julie K., Plesa, Gabriela, Siegel, Donald L., Chew, Anne, Levine, Bruce L., Berger, Shelley L., Moon, Edmund K., Albelda, Steven M., Fraietta, Joseph A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313923/ https://www.ncbi.nlm.nih.gov/pubmed/37224816 http://dx.doi.org/10.1016/j.xcrm.2023.101053 |
Ejemplares similares
-
BLIMP1 and NR4A3 Transcription Factors Reciprocally Regulate Antitumor CAR T-cell Stemness and Exhaustion
por: Jung, In-Young, et al.
Publicado: (2022) -
TOX2 coordinates with TET2 to positively regulate central memory differentiation in human CAR T cells
por: Collins, Sierra M., et al.
Publicado: (2023) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
por: Klampatsa, Astero, et al.
Publicado: (2017) -
CAR-T Cells Hit the Tumor Microenvironment: Strategies to Overcome Tumor Escape
por: Rodriguez-Garcia, Alba, et al.
Publicado: (2020) -
CAR T Cell Therapy of Non-hematopoietic Malignancies: Detours on the Road to Clinical Success
por: Long, Kristen B., et al.
Publicado: (2018)